title: Characterization and optimization of heroin hapten-BSA conjugates: method development for the synthesis of reproducible hapten-based vaccines.
abstract: A potential new treatment for drug addiction is immunization with vaccines that induce antibodies that can abrogate the addictive effects of the drug of abuse. One of the challenges in the development of a vaccine against drugs of abuse is the availability of an optimum procedure that gives reproducible and high yielding hapten-protein conjugates. In this study, a heroin/morphine surrogate hapten (MorHap) was coupled to bovine serum albumin (BSA) using maleimide-thiol chemistry. MorHap-BSA conjugates with 3, 5, 10, 15, 22, 28, and 34 haptens were obtained using different linker and hapten ratios. Using this optimized procedure, MorHap-BSA conjugates were synthesized with highly reproducible results and in high yields. The number of haptens attached to BSA was compared by 2,4,6-trinitrobenzenesulfonic acid (TNBS) assay, modified Ellman's test and matrix assisted laser desorption ionization time-of-flight mass spectrometry (MALDI-TOF MS). Among the three methods, MALDI-TOF MS discriminated subtle differences in hapten density. The effect of hapten density on enzyme-linked immunosorbent assay (ELISA) performance was evaluated with seven MorHap-BSA conjugates of varying hapten densities, which were used as coating antigens. The highest antibody binding was obtained with MorHap-BSA conjugates containing 3-5 haptens. This is the first report that rigorously analyzes, optimizes and characterizes the conjugation of haptens to proteins that can be used for vaccines against drugs of abuse. The effect of hapten density on the ELISA detection of antibodies against haptens demonstrates the importance of careful characterization of the hapten density by the analytical techniques described.
authors.affiliation: Laboratory of Adjuvant and Antigen Research, US Military HIV Research Program, Walter Reed Army Institute of Research, 503 Robert Grant Avenue, Silver Spring, MD, 20910, USA.
authors.forename: Oscar B
authors.initials: OB
authors.lastname: Torres
authors.forename: Rashmi
authors.initials: R
authors.lastname: Jalah
authors.forename: Kenner C
authors.initials: KC
authors.lastname: Rice
authors.forename: Fuying
authors.initials: F
authors.lastname: Li
authors.forename: Joshua F G
authors.initials: JF
authors.lastname: Antoline
authors.forename: Malliga R
authors.initials: MR
authors.lastname: Iyer
authors.forename: Arthur E
authors.initials: AE
authors.lastname: Jacobson
authors.forename: Mohamed Nazim
authors.initials: MN
authors.lastname: Boutaghou
authors.forename: Carl R
authors.initials: CR
authors.lastname: Alving
authors.forename: Gary R
authors.initials: GR
authors.lastname: Matyas
mesh_terms: D000818:Animals; D002417:Cattle; D060326:Chemistry Techniques, Synthetic / Q000379:methods*; D004797:Enzyme-Linked Immunosorbent Assay; D006241:Haptens / Q000737:chemistry / Q000276:immunology; D003932:Heroin / Q000737:chemistry* / Q000276:immunology; D006801:Humans; D013058:Mass Spectrometry; D051379:Mice; D012710:Serum Albumin, Bovine / Q000737:chemistry* / Q000276:immunology; D019966:Substance-Related Disorders / Q000517:prevention & control*; D014612:Vaccines / Q000138:chemical synthesis* / Q000737:chemistry / Q000276:immunology
chemical_list: D006241:Haptens; D014612:Vaccines; D012710:Serum Albumin, Bovine; D003932:Heroin
references.citation: Vaccine. 2014 Mar 14;32(13):1473-9
references.pmid: 24486371
references.citation: Bioconjug Chem. 2004 Jan-Feb;15(1):168-73
references.pmid: 14733597
references.citation: J Immunol Methods. 1987 Jul 16;101(1):63-71
references.pmid: 3611793
references.citation: Proteins. 2014 Sep;82(9):1734-46
references.pmid: 24488795
references.citation: J Immunol Methods. 1994 Jan 3;167(1-2):121-7
references.pmid: 7905897
references.citation: J Immunol Methods. 1993 Aug 26;164(1):119-30
references.pmid: 8360501
references.citation: Anal Chem. 2003 Nov 1;75(21):5797-805
references.pmid: 14588020
references.citation: Biochemistry. 1993 Jul 27;32(29):7574-80
references.pmid: 8338853
references.citation: Anal Chem. 2013 Apr 2;85(7):3483-8
references.pmid: 23463947
references.citation: Mol Immunol. 2012 Oct;52(3-4):174-82
references.pmid: 22677715
references.citation: J Pharmacol Exp Ther. 2013 Feb;344(2):397-406
references.pmid: 23220743
references.citation: J Exp Med. 1936 Sep 30;64(4):625-39
references.pmid: 19870557
references.citation: J Exp Med. 1935 Apr 30;61(5):643-56
references.pmid: 19870383
references.citation: J Am Soc Mass Spectrom. 2010 Nov;21(11):1922-9
references.pmid: 20829063
references.citation: Adv Protein Chem. 2002;61:119-60
references.pmid: 12461823
references.citation: Nat Chem Biol. 2011 Nov 15;7(12):876-84
references.pmid: 22086289
references.citation: Bioconjug Chem. 1994 Nov-Dec;5(6):631-5
references.pmid: 7873666
references.citation: PLoS One. 2013 Oct 01;8(10):e76557
references.pmid: 24098532
references.citation: Methods Mol Med. 2008;138:167-82
references.pmid: 18612607
references.citation: PLoS Pathog. 2010 May 27;6(5):e1000908
references.pmid: 20523901
references.citation: J Theor Biol. 1988 Jun 7;132(3):319-35
references.pmid: 2465456
references.citation: Analyst. 2014 Jan 21;139(2):439-45
references.pmid: 24308031
references.citation: Nat Protoc. 2012 Nov;7(11):1964-9
references.pmid: 23037311
references.citation: Anal Chem. 2013 Mar 19;85(6):3425-32
references.pmid: 23394312
references.citation: J Med Chem. 2011 Jul 28;54(14):5195-204
references.pmid: 21692508
references.citation: J Med Chem. 2011 Jul 28;54(14):5221-8
references.pmid: 21682289
references.citation: J Biol Chem. 1983 Dec 10;258(23):14433-7
references.pmid: 6643494
references.citation: Anal Biochem. 1966 Mar;14(3):328-36
references.pmid: 4161471
references.citation: J Mass Spectrom. 2013 Jul;48(7):807-12
references.pmid: 23832936
references.citation: Lancet. 2013 Nov 9;382(9904):1564-74
references.pmid: 23993281
references.citation: Mol Immunol. 2013 Dec;56(4):588-98
references.pmid: 23911417
references.citation: J Immunol Methods. 1988 Oct 4;113(1):3-15
references.pmid: 3049824
references.citation: Vaccine. 2013 Jun 10;31(26):2804-10
references.pmid: 23624097
references.citation: Vaccine. 2012 Jun 29;30(31):4617-24
references.pmid: 22583811